vs

Side-by-side financial comparison of Fulgent Genetics, Inc. (FLGT) and LandBridge Co LLC (LB). Click either name above to swap in a different company.

Fulgent Genetics, Inc. is the larger business by last-quarter revenue ($71.1M vs $51.0M, roughly 1.4× LandBridge Co LLC). On growth, LandBridge Co LLC posted the faster year-over-year revenue change (16.0% vs -3.2%). Over the past eight quarters, LandBridge Co LLC's revenue compounded faster (40.2% CAGR vs 0.1%).

Fulgent Genetics, Inc. is a molecular diagnostics technology firm that develops and offers genetic testing services including carrier screening, oncology testing, infectious disease detection, and hereditary condition analysis, serving clinical providers, pharma firms, research institutions and public health groups primarily in North America.

FLGT vs LB — Head-to-Head

Bigger by revenue
FLGT
FLGT
1.4× larger
FLGT
$71.1M
$51.0M
LB
Growing faster (revenue YoY)
LB
LB
+19.2% gap
LB
16.0%
-3.2%
FLGT
Faster 2-yr revenue CAGR
LB
LB
Annualised
LB
40.2%
0.1%
FLGT

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
FLGT
FLGT
LB
LB
Revenue
$71.1M
$51.0M
Net Profit
$17.9M
Gross Margin
30.2%
Operating Margin
21.1%
57.2%
Net Margin
35.0%
Revenue YoY
-3.2%
16.0%
Net Profit YoY
15.6%
EPS (diluted)
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FLGT
FLGT
LB
LB
Q1 26
$71.1M
$51.0M
Q4 25
$83.3M
$56.8M
Q3 25
$84.1M
$50.8M
Q2 25
$81.8M
$47.5M
Q1 25
$73.5M
$44.0M
Q4 24
$76.2M
$36.5M
Q3 24
$71.7M
$28.5M
Q2 24
$71.0M
$26.0M
Net Profit
FLGT
FLGT
LB
LB
Q1 26
$17.9M
Q4 25
$-23.4M
$8.1M
Q3 25
$-6.6M
$8.1M
Q2 25
$-19.0M
$7.5M
Q1 25
$-11.5M
$6.5M
Q4 24
$-5.9M
$49.3M
Q3 24
$-14.6M
$2.7M
Q2 24
$-8.7M
$-57.7M
Gross Margin
FLGT
FLGT
LB
LB
Q1 26
30.2%
Q4 25
39.1%
Q3 25
42.2%
Q2 25
42.1%
Q1 25
38.6%
Q4 24
41.8%
Q3 24
37.3%
Q2 24
37.3%
Operating Margin
FLGT
FLGT
LB
LB
Q1 26
21.1%
57.2%
Q4 25
-43.5%
60.0%
Q3 25
-18.3%
60.8%
Q2 25
-24.1%
60.0%
Q1 25
-26.9%
57.0%
Q4 24
-21.2%
49.4%
Q3 24
-23.8%
11.2%
Q2 24
-26.6%
-197.4%
Net Margin
FLGT
FLGT
LB
LB
Q1 26
35.0%
Q4 25
-28.1%
14.2%
Q3 25
-7.9%
15.9%
Q2 25
-23.2%
15.8%
Q1 25
-15.7%
14.7%
Q4 24
-7.7%
135.2%
Q3 24
-20.4%
9.3%
Q2 24
-12.3%
-222.1%
EPS (diluted)
FLGT
FLGT
LB
LB
Q1 26
$0.04
Q4 25
$0.24
Q3 25
$0.26
Q2 25
$0.24
Q1 25
$0.20
Q4 24
Q3 24
$-0.04
Q2 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FLGT
FLGT
LB
LB
Cash + ST InvestmentsLiquidity on hand
$23.4M
$29.7M
Total DebtLower is stronger
$433.0K
Stockholders' EquityBook value
Total Assets
$1.2B
$1.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FLGT
FLGT
LB
LB
Q1 26
$23.4M
$29.7M
Q4 25
$50.2M
$30.7M
Q3 25
$117.6M
$28.3M
Q2 25
$87.9M
$20.3M
Q1 25
$67.3M
$14.9M
Q4 24
$55.1M
$37.0M
Q3 24
$58.0M
$14.4M
Q2 24
$65.1M
$24.6M
Total Debt
FLGT
FLGT
LB
LB
Q1 26
$433.0K
Q4 25
$570.7M
Q3 25
$366.1M
Q2 25
$370.9M
Q1 25
$375.5M
Q4 24
$385.5M
Q3 24
$242.4M
Q2 24
$360.8M
Stockholders' Equity
FLGT
FLGT
LB
LB
Q1 26
Q4 25
$1.1B
$340.3M
Q3 25
$1.1B
$272.0M
Q2 25
$1.1B
$266.4M
Q1 25
$1.1B
$217.0M
Q4 24
$1.1B
$211.8M
Q3 24
$1.1B
$97.2M
Q2 24
$1.1B
$296.4M
Total Assets
FLGT
FLGT
LB
LB
Q1 26
$1.2B
$1.4B
Q4 25
$1.2B
$1.4B
Q3 25
$1.2B
$1.1B
Q2 25
$1.2B
$1.1B
Q1 25
$1.2B
$1.0B
Q4 24
$1.2B
$1.0B
Q3 24
$1.2B
$689.9M
Q2 24
$1.2B
$710.5M
Debt / Equity
FLGT
FLGT
LB
LB
Q1 26
Q4 25
1.68×
Q3 25
1.35×
Q2 25
1.39×
Q1 25
1.73×
Q4 24
1.82×
Q3 24
2.49×
Q2 24
1.22×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FLGT
FLGT
LB
LB
Operating Cash FlowLast quarter
$41.1M
Free Cash FlowOCF − Capex
$40.9M
FCF MarginFCF / Revenue
80.3%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
2.30×
TTM Free Cash FlowTrailing 4 quarters
$232.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FLGT
FLGT
LB
LB
Q1 26
$41.1M
Q4 25
$-78.1M
$126.3M
Q3 25
$11.1M
$34.9M
Q2 25
$-30.2M
$37.3M
Q1 25
$-4.4M
$15.9M
Q4 24
$25.0M
$67.6M
Q3 24
$-15.5M
$7.5M
Q2 24
$4.3M
$16.0M
Free Cash Flow
FLGT
FLGT
LB
LB
Q1 26
$40.9M
Q4 25
$-83.1M
$122.0M
Q3 25
$5.1M
$33.7M
Q2 25
$-37.0M
$36.1M
Q1 25
$-9.1M
$15.8M
Q4 24
$21.2M
$66.7M
Q3 24
$-35.0M
$7.1M
Q2 24
$-8.7M
$15.7M
FCF Margin
FLGT
FLGT
LB
LB
Q1 26
80.3%
Q4 25
-99.7%
214.9%
Q3 25
6.0%
66.3%
Q2 25
-45.2%
75.9%
Q1 25
-12.5%
36.0%
Q4 24
27.9%
182.6%
Q3 24
-48.8%
25.1%
Q2 24
-12.2%
60.4%
Capex Intensity
FLGT
FLGT
LB
LB
Q1 26
Q4 25
6.0%
7.5%
Q3 25
7.2%
2.3%
Q2 25
8.3%
2.6%
Q1 25
6.4%
0.2%
Q4 24
5.0%
2.7%
Q3 24
27.2%
1.1%
Q2 24
18.2%
1.4%
Cash Conversion
FLGT
FLGT
LB
LB
Q1 26
2.30×
Q4 25
15.68×
Q3 25
4.31×
Q2 25
4.98×
Q1 25
2.46×
Q4 24
1.37×
Q3 24
2.80×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FLGT
FLGT

Segment breakdown not available.

LB
LB

Other$14.2M28%
Easements and other surface-related revenues$11.6M23%
Surface use royalties - related party$11.0M22%
Resource sales$5.2M10%
Resource royalties$4.3M8%
Easements and other surface-related revenues - related party$3.2M6%
Resource royalties - related party$1.3M2%
Resource sales - related party$205.0K0%

Related Comparisons